Prosecution Insights
Last updated: October 27, 2026

Nhu Tran, USPTO Patent Examiner

Listed by the USPTO as TRAN, NHU

Tech Center 3700 • Art Units: 3771 3781

This examiner grants 69% of resolved cases

Analysis

TRAN, NHU works in Tech Center 3700 and Art Unit 3771. The profile records 134 resolved cases, a 68.7% allowance rate, and a 17.2% interview lift. The median time to allowance is 1125 days. The docket is smaller than many substantial examiner records, but its allowance and interview figures still provide useful signals for applicants evaluating response options and expected prosecution effort.

The companies listed are 3M Company, 3M Innovative Properties Company, and Boston Scientific Corporation. The leading firms are BALLARD SPAHR LLP, BIRCH STEWART KOLASCH & BIRCH, LLP, and Budzyn IP Law, LLC. Practitioners should focus on a technically coherent claim narrative and use interviews to test whether targeted amendments address the examiner's principal concerns.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.7%
Allow Rate
-1.3% vs TC avg
178
Total Applications
+17.2%
Interview Lift
1125
Avg Prosecution Days
Based on 134 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
13.3%
§102 Novelty
52.1%
§103 Obviousness
27.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18537471 DRESSING WITH PROTRUDING LAYER ALLOWING FOR CLEANSING OF WOUND BED MACRO DEFORMATIONS Final Rejection 3M Innovative Properties Company
18352073 PROGRESSIVELY EXPANDING ANTI-MIGRATION STENT Non-Final OA Boston Scientific Scimed, Inc.
18777663 ABSORBENT CORE AND ABSORBENT ARTICLE COMPRISING THE SAME Non-Final OA The Procter & Gamble Company
18673408 TRANSPARENT PEEL AND PLACE DRESSING FOR NEGATIVE-PRESSURE THERAPY Final Rejection Solventum Intellectual Properties Company
17470679 WOUND THERAPY SYSTEM WITH WOUND VOLUME ESTIMATION Non-Final OA Solventum Intellectual Properties Company
16959651 Peel And Place Dressing For Thick Exudate And Instillation Non-Final OA Solventum Intellectual Properties Company
17280291 THERAPEUTIC SUBSTANCE STORAGE AND DELIVERY Non-Final OA Cochlear Limited
18982637 SYSTEMS AND METHODS FOR USING NEGATIVE PRESSURE WOUND THERAPY TO MANAGE OPEN ABDOMINAL WOUNDS Non-Final OA Smith & Nephew, Inc.
18239896 Medical Device Comprising Self-Lubricating Rubber Component Final Rejection Becton, Dickinson and Company
17973683 MECHANICAL VACUUM DRESSING FOR MECHANICALLY MANAGING, PROTECTING AND SUCTIONING SMALL INCISIONAL WOUNDS Final Rejection Cornell University
18717159 Blood Treatment Apparatus With A Coupled Blood Pump And Compressed Pressure Device Final Rejection Fresenius Medical Care Deutschland GmbH
17772479 DRESSING WITH AREA MANAGEMENT FOR EXTREMITIES Final Rejection KCI Manufacturing Unlimited Company

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Nhu Tran's allowance rate?

68.7% of resolved applications examined by Nhu Tran were allowed (134 resolved cases), compared with 65.9% across Art Unit 3771 over the last five years.

Does an interview help with examiner Nhu Tran?

This examiner's interview lift is +17.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Nhu Tran take to allow a patent?

Applications allowed by Nhu Tran took 1,125 days on average from filing to allowance.

Which art unit does examiner Nhu Tran work in?

Nhu Tran examines applications in Art Unit 3771 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month